GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (CHIX:HLUNBc) » Definitions » 12-1 Month Momentum %

H. Lundbeck AS (CHIX:HLUNBC) 12-1 Month Momentum % : 26.40% (As of Dec. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-15), H. Lundbeck AS's 12-1 Month Momentum % is 26.40%.

The industry rank for H. Lundbeck AS's 12-1 Month Momentum % or its related term are showing as below:

CHIX:HLUNBc's 12-1 Month Momentum % is ranked better than
76.95% of 1063 companies
in the Drug Manufacturers industry
Industry Median: -4.2 vs CHIX:HLUNBc: 26.40

Competitive Comparison of H. Lundbeck AS's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's 12-1 Month Momentum % falls into.



H. Lundbeck AS  (CHIX:HLUNBc) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H. Lundbeck AS  (CHIX:HLUNBc) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


H. Lundbeck AS 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


H. Lundbeck AS Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines